Clinical Trial

Nutrition Impact on PRGF Treatment for Tendinopathy

Study acronym: NUTRITENDON
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2024 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Given the close correlation reported in the literature between onset and progression of tendon pathology in subjects affected by the alteration of metabolic disorders such as obesity, diabetes mellitus and lipidic metabolic alterations, with the present study the association between the nutritional state, metabolic profile and clinical outcome of patients following treatment with blood-derived orthobiological for shoulder tendinopathies will be evaluated. The primary aim of this study is to identify the proportion of tendinopatic patients responsive and non-responsive to treatment with "Platelet rich growth factors" PRGF at six months follow up and the correlation with their nutritional status.
Trial Details
NCT Number NCT06536582
Lead Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions Shoulder Tendinopathy, Metabolic Alterations
Enrollment 52 participants
Start Date 2024-02-15
Primary Completion 2026-08-15 (estimated)
Study Completion 2027-02-15 (estimated)
Updated on ClinicalTrials.gov 2024-08-05